CMG Pharmaceutical
CMG제약 · 058820
Health Care Pharmaceuticals · KOSDAQ
Market cap US$125.9M (₩173.7B)
Overview
CMG Pharmaceutical makes medicines and health-supplement products, with a core focus on a thin, fast-dissolving oral film, a strip placed on the tongue that delivers a drug without water, using its proprietary STARFILM Technology.
Its products reach patients and consumers through pharmaceutical and health-care channels. Listed on KOSDAQ, Korea's tech and small-cap board, the company is expanding its product portfolio beyond its current medicines into oncology, anti-aging, eye care, health supplements, and mother-and-baby categories, while also pursuing new and improved-formulation drug development.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$68M
- FY2024US$71.8M
- FY2025US$76.3M
Operating profit
- FY2023US$2.2M
- FY2024US$739.4K
- FY2025−US$2.7M
Net income
- FY2023US$4.7M
- FY2024US$2M
- FY2025−US$7.3M
Key ratios (FY2025)
Why it matters
CMG Pharmaceutical is described in its filing as a core affiliate of the Cha Bio Group, a Korean life-sciences conglomerate.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?